Compagno, D.; Tiraboschi, C.; Garcia, J.D.; Rondón, Y.; Corapi, E.; Velazquez, C.; Laderach, D.J.
Galectins as Checkpoints of the Immune System in Cancers, Their Clinical Relevance, and Implication in Clinical Trials. Biomolecules 2020, 10, 750.
https://doi.org/10.3390/biom10050750
AMA Style
Compagno D, Tiraboschi C, Garcia JD, Rondón Y, Corapi E, Velazquez C, Laderach DJ.
Galectins as Checkpoints of the Immune System in Cancers, Their Clinical Relevance, and Implication in Clinical Trials. Biomolecules. 2020; 10(5):750.
https://doi.org/10.3390/biom10050750
Chicago/Turabian Style
Compagno, Daniel, Carolina Tiraboschi, José Daniel Garcia, Yorfer Rondón, Enrique Corapi, Carla Velazquez, and Diego José Laderach.
2020. "Galectins as Checkpoints of the Immune System in Cancers, Their Clinical Relevance, and Implication in Clinical Trials" Biomolecules 10, no. 5: 750.
https://doi.org/10.3390/biom10050750
APA Style
Compagno, D., Tiraboschi, C., Garcia, J. D., Rondón, Y., Corapi, E., Velazquez, C., & Laderach, D. J.
(2020). Galectins as Checkpoints of the Immune System in Cancers, Their Clinical Relevance, and Implication in Clinical Trials. Biomolecules, 10(5), 750.
https://doi.org/10.3390/biom10050750